跳至主要内容
临床试验/ACTRN12616000522415
ACTRN12616000522415终止4 期

Cervical Ripening Using Misoprostol vs Dinoprostone: A randomised, triple-blinded, interventional study comparing safety and efficacy in primiparous women

John Hunter Hospital0 个研究点目标入组 208 人开始时间: 2016年4月21日最近更新:
适应症

试验速览

阶段
4 期
状态
终止
入组人数
208

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • 1) Pregnant women between 37+0 and 41+4 weeks gestation
  • 2) Having first baby
  • 3) Induction of labour deemed medically indicated
  • 4) Bishops score less than or equal to 4
  • 5) age >=18
  • 6) BMI <50 at booking visit

排除标准

  • 1) Active labour
  • 2) Ruptured membranes
  • 3) Non-cephalic presentation
  • 4) Previous caesarean section or other uterine surgery
  • 5) Unexplained vaginal bleeding >24 weeks gestation
  • 6) Suspected or known chorioamnionitis
  • 7) Suspected or known fetal compromise (abnormal antenatal fetal heart rate pattern, ultrasound showing fetal growth <10th centile, oligohydramnios, polyhydramnios, abnormal dopplers)
  • 8) Unable to read or speak English without the aid of an interpreter

研究者

相似试验